SCHEMBL20697237

SCHEMBL20697237

CCNc1cccn(-c2cccnc2)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.44
MAT2A P31153 1/20 0.44
CYP3A4 P08684 2/20 0.42
CYP2A6 P11509 2/20 0.42
CYP2E1 P05181 1/20 0.42
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
HTT P42858 1/20 0.39
MEN1 O00255 1/20 0.38
USP2 O75604 1/20 0.38
CASP1 P29466 1/20 0.38
BRCA1 P38398 1/20 0.38
CASP7 P55210 1/20 0.38
KMT2A Q03164 1/20 0.38
GRM1 Q13255 3/20 0.38
ALDH1A1 P00352 2/20 0.38
AR P10275 1/20 0.38
ALOX12 P18054 1/20 0.37
EP300 Q09472 1/20 0.37
KAT2B Q92831 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21285312 0.84 CYP3A4 (0.45) ELANEMAT2ACYP3A4CYP2A6CYP2E1
SCHEMBL20687686 0.80 CYP3A4 (0.42) ELANECYP3A4CYP2A6CYP2E1HTT
SCHEMBL21258570 0.77 RXFP1 (0.44) MEN1USP2CASP1CASP7KMT2A
SCHEMBL2692307 0.76 MAT2A (0.41) ELANEMAT2ACYP3A4CYP2A6CYP2E1
SCHEMBL21246043 0.76 POLB (0.44) MEN1USP2CASP1BRCA1CASP7
SCHEMBL31456729 0.75 CYP2A6 (0.53) ELANECYP3A4CYP2A6CYP2E1HTT
Hydrochloric Acid SCHEMBL15346752 0.75 MAT2A (0.40) ELANEMAT2ACYP3A4CYP2A6CYP2E1
Ammonia Solution, Strong SCHEMBL20569938 0.75 MAT2A (0.40) ELANEMAT2ACYP3A4CYP2A6CYP2E1
Hydrochloric Acid SCHEMBL2688884 0.75 MAT2A (0.40) ELANEMAT2ACYP3A4CYP2A6CYP2E1
SCHEMBL21285306 0.75 TYK2 (0.42) MEN1USP2CASP1BRCA1CASP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046698-B2 TYK2 inhibitors and uses thereof NIMBUS LAKSHMI, INC. (US) 2021-06-29 US disclosed
US-20190031664-A1 TYK2 INHIBITORS AND USES THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2019-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11046698-B2 TYK2 inhibitors and uses thereof TYK2, JAK2, JAK1 ELANE 4836/4885MAT2A 1724/4885CYP3A4 4404/4885
US-20190031664-A1 TYK2 INHIBITORS AND USES THEREOF TYK2, JAK2, JAK1 ELANE 4836/4885MAT2A 1724/4885CYP3A4 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.